Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocacy groups in rare cancers
•
1 gefällt mir•611 views
![About the CML Advocates Network ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Empfohlen
Empfohlen
Weitere ähnliche Inhalte
Was ist angesagt?
Was ist angesagt? (19)
Ähnlich wie Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocacy groups in rare cancers
Ähnlich wie Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocacy groups in rare cancers (20)
Mehr von European School of Oncology
Mehr von European School of Oncology (20)
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocacy groups in rare cancers
- 1. Patient advocacy groups in rare cancers Jan Geissler Co-founder, CML Advocates Network Chair, LeukaNET Founder, Patvocates http://www.cmladvocates.net
- 8. Role #1 Patient Information and Support
- 12. Role #2 Influencing the political agenda
- 14. Role #3 Patients' participation in (rare) cancer research